Figure S10 from B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response

Key Points

Increased cxcl10 secretion was observed after repetitive stimulation of b7-h3 car t cells compared to baseline levels.
The b7-h3 car t cells showed effectiveness against ependymomas, but their impact is limited by tumor size and immune response challenges.
CXCL10 secretion correlates with the immune response, impacting the efficacy of b7-h3 car t cells against tumors.
Repetitive stimulation of the car t cells enhances their secretory activity, highlighting their potential in cancer therapy.

Figure S10 demonstrates increased cxcl10 secretion in b7-h3 car t cells against ependymomas, indicating immune response limitations.

Figure S10 shows increased CXCL10 secretion following repetitive stimulation compared to baseline secretion of B7-H3.CAR T-cells and EPN cells.

No takes yet. Share an insight, caveat, or question.

Mehta et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share